Macquarie Group
ARCT icon

Macquarie Group’s Arcturus Therapeutics ARCT Stock Holding History

Macquarie Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-288
Closed -$4.83K – 2455
2022
Q2 		$5K Hold
288
– – ﹤0.01% 2517
2022
Q1 		$8 Hold
288
– – ﹤0.01% 2535
2021
Q4 		$11K Hold
288
– – ﹤0.01% 2493
2021
Q3 		$14K Hold
288
– – ﹤0.01% 2500
2021
Q2 		$10K Hold
288
– – ﹤0.01% 2466
2021
Q1 		$12K Sell
288
-136
-32% -$8.11K ﹤0.01% 2363
2020
Q4 		$18K Hold
424
– – ﹤0.01% 2239
2020
Q3 		$18K Hold
424
– – ﹤0.01% 2184
2020
Q2 		$20K Sell
424
-1,701
-80% -$58.6K ﹤0.01% 2158
2020
Q1 		$29K Buy
+2,125
New +$27.2K ﹤0.01% 1890

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return